Fosamax (Alendronate) is a type of drug known as biphosphonate and is used to treat osteoporosis in post menopausal women. Although these drugs are designed to strengthen bones, for some reasons not yet understood, they can have the opposite effect and weaken bones or cause a serious bone condition known as osteonecrosis of the jaw. The Food and Drug Administration and Novartis, the manufacturer of bisphosphonates, issued a warning to health care professionals on September 24, 2004. Symptoms of osteonecrosis of the jaw include loosening of teeth, severe infections and swelling. If you take any of these drugs, we strongly advise you to discuss this with your physician and dentist.

Fosamax´┐┐ is a bisphosphonate medication used for bone loss. However, similar bisphosphonates have been implicated in the serious necrosis of the jaw and other bones, a condition known as "osteonecrosis."

In the U.S. Package Insert for both Aredia and Zometa, the following information on osteonecrosis had previously been added to the Adverse Reactions section under Post-Marketing Experience.

"Cases of osteonecrosis (primarily involving the jaws) have been reported in patients treated with bisphosphonates. The majority of the reported cases are in cancer patients attendant to a dental procedure. Osteonecrosis of the jaw has multiple well documented risk factors including a diagnosis of cancer, concomitant therapies (e.g., chemotherapy, radiotherapy, corticosteroids) and co-morbid conditions (e.g., anemia, coagulopathies, infection, pre-existing oral disease). Although causality cannot be determined, it is prudent to avoid dental surgery as recovery may be prolonged."
Please Note:  The highest risks are for those individuals who have been on IV bisphosphonates and for those taking oral bisphosphonates for at least three years.  Maintaining excellent oral health with regular dental exams and cleanings and proper home care significantly reduces the risks.
Long Island Cosmetic Dentists
Dental News
Gary L. Sandler, DDS & Bonnie E. Lipow, DDS
201 Moreland Road, Suite #8
Hauppauge, NY 11788
631-499-1800

News of Interest affecting Dental Treatment

Home PageDr. Sandler | Dr. LipowServices  | Dental Implants | Periodontal Disease | Common Dental ProblemsFAQ's
Patient Testimonials | Maps & Directions | Photo Gallery | Photo Gallery 2 | Cosmetic Dentistry |  Fresh Breath | Cavity Control
 Complimentary Smile Analysis | Contact Us |  Policies and Hours | Internet LinksTerms of Use AgreementPrivacy Policy |Site Map
 

Long Island Cosmetic Dentists

smilesapart015002.gif
Click here for new Premedication Guidelines
Wellness.com
Merchant Circle.com
Heathgrades.com
Google Maps
SuperPages.com
CitiDexLI.com
Snap-On-Smile
Despite popular belief, gum disease hasn't been proven to cause atherosclerotic heart disease or stroke, and treating gum disease hasn't been proven to prevent heart disease or stroke, according to a new scientific statement published in Circulation, an American Heart Association journal.
Keeping teeth and gums healthy is important for your overall health. However, an American Heart
Association expert committee -- made up of cardiologists, dentists and infectious diseases specialists -- found
no conclusive scientific evidence that gum disease, also known as periodontal disease, causes or increases
the rates of cardiovascular diseases. However, many studies and most authorities do support an as-yet-
unexplained association between gum disease and several serious health conditions, including heart disease.
In a recent study, the researchers found that prolonged consumption of sports drinks may be linked to a condition known as erosive tooth wear, in which acids eat away the tooth's smooth hard enamel coating and trickle into the bonelike material underneath, causing the tooth to soften and weaken. The condition affects one in 15 Americans and can result in severe tooth damage and even tooth loss if left untreated.

Some dentists may be exposing young patients to unnecessary radiation when they order 3-D X-ray imaging for simple orthodontic cases or other dental diagnostic procedures before considering traditional 2-D imaging, suggests a paper published by University of Michigan faculty.

There is ongoing debate in the orthodontic community over if and when to use cone beam computed tomography (CBCT) for orthodontic diagnosis and treatment planning, said Dr. Sunil Kapila, lead author of the paper and chair of the Department of Orthodontics and Pediatric Dentistry at the U-M School of Dentistry.
The recommended level of fluoride in U.S. drinking water supplies should be lowered to prevent dental problems, according to a joint announcement today by officials from the Department of Health and Human Services (HHS) and the Environmental Protection Agency (EPA). The HHS is recommending that water supplies contain 0.7 milligrams of fluoride per liter of water, replacing the current recommended range of 0.7 to 1.2 milligrams.
Learn more...
Learn more...
When Faye Lewis became concerned about her painful new bridgework, she had it checked out and received some disturbing news: Her bridge was manufactured in China and tainted with lead. More dentists are using crowns and bridges made in China. According to the United State Customs Office, the number of dental products coming into the United States from China has doubled in the last year. OUR OFFICE USES THE BEST DENTAL LAB AVAILABLE THAT DOES ALL THEIR OWN WORK IN HOUSE ....but
Learn more...
Learn more...
Dental Amalgam Safety - FDA Position
Gum Disease, Heart Disease and Stroke
Dental Crowns May Contain Lead or Other Contaminants
Sport Drinks Can Cause Tooth Erosions
Beware Overuse of 3D X-ray Technique (Cone Beam CBCT)
U.S. Wants to Reduce Levels of Fluoride Intake
Fosamax Health Warning
smilesapart015001.gif
See Perio.org
See ADA
See NHS.UK
Learn more...
The FDA released letters denying three petitions to ban or restrict dental amalgam, telling one person, "FDA finds that the information you submitted, as well as other information that we have reviewed, does not support a finding that dental amalgam presents a substantial deception or an unreasonable and substantial risk of illness or injury." Letters to the three petitioners said in conclusion, "Even so, FDA continues to evaluate the safety of dental amalgam and will take any further actions that are warranted."
<